About IMMAGE BIOTHERAPEUTICS CORP
Sector
Industry
CEO
Zhi Cong Mou
Headquarters
Bethesda
Founded
2012
FIGI
BBG003PYLKF7
Immage Biotherapeutics Corp. is a biotechnology company, which develops novel immunotherapy biologics to treat various cancers. The firm develops, markets, and licenses its patented immunotherapy candidate for MAGE A. It encompasses vaccines, oncolytic viruses, adjuvants, and adoptive t-cell technologies. The company was founded by Anton Dormer and Mahesh Narayanan in 2012 and is headquartered in Bethesda, MD.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of IMMG is 0.000001 USD — it hasn't changed in the past 24 hours. Watch IMMAGE BIOTHERAPEUTICS CORP stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange IMMAGE BIOTHERAPEUTICS CORP stocks are traded under the ticker IMMG.
IMMG reached its all-time high on Apr 3, 2017 with the price of 1.620000 USD, and its all-time low was 0.000001 USD and was reached on Oct 11, 2017. View more price dynamics on IMMG chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
IMMG stock is 0% volatile and has beta coefficient of 0. Track IMMAGE BIOTHERAPEUTICS CORP stock price on the chart and check out the list of the most volatile stocks — is IMMAGE BIOTHERAPEUTICS CORP there?
Yes, you can track IMMAGE BIOTHERAPEUTICS CORP financials in yearly and quarterly reports right on TradingView.
No, IMMG doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, IMMG shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade IMMAGE BIOTHERAPEUTICS CORP stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So IMMAGE BIOTHERAPEUTICS CORP technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating IMMAGE BIOTHERAPEUTICS CORP stock shows the sell signal. See more of IMMAGE BIOTHERAPEUTICS CORP technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.